Status:
COMPLETED
Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
St. Petersburg State Pavlov Medical University
Conditions:
Effect of Individualized Nutrition on Quality of Life
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Aim Allogeneic stem cell transplantation (allo-SCT) combined with several cycles of intensive chemotherapy is the only curative treatment for several malignant blood diseases. Most allo-SCT patients ...
Detailed Description
Patients and methods A minimum sample of 100 patients will be included in the study. This is the result of a power calculation where a difference of 15 of global QoL is the primary end-point. All pat...
Eligibility Criteria
Inclusion
- acute lymphatic leukaemia, acute myeloid leukaemia, chronic myeloproliferative disease and chronic myelogenous leukaemia and other disorders accepted for allogeneic stem cell transplantation, following myeloablative conditioning
Exclusion
- unable to give informed consent
- unable to adhere to protocol due to reasons unrelated to the hematological condition
Key Trial Info
Start Date :
August 10 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT01181076
Start Date
August 10 2010
End Date
March 1 2017
Last Update
January 22 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0027
2
Pavlov State Medical University of St. Petersburg
Saint Petersburg, Russia